AMETEK, Inc. vs 10X Genomics Inc — how do they compare? AMETEK, Inc. trades at $255.78 (market cap $58.76B), while 10X Genomics Inc trades at $59.23 (market cap $7.61B). The key difference: AMETEK, Inc. is far larger — about 7.7× 10X Genomics Inc's market cap, and AMETEK, Inc. pays a 0.53% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| AME | TXG | |
|---|---|---|
Market Cap | $58.76B | $7.61B |
Sector | Industrials | Health |
52-Week High | $256.30 | $58.57 |
52-Week Low | $179.28 | $11.34 |
Enterprise Value | $60.30B | $7.14B |
Dividend Yield | 0.53% | — |
Trailing returns across standard periods
Ametek is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. About half of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.
Read more on AME →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →